MedTrace Logo

Cerebral Oxygenation and Autoregulation in Preterm Infants

NCT02147769 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 111

Last updated 2020-04-07

Study results available
· View outcomes & findings →

Summary

Premature infants are at high risk for variations in blood pressure and oxygenation during the first few days of life. The immaturity of the premature brain may further predispose these infants to death or the development of neurologic problems. The relationship between unstable blood pressure and oxygen levels and brain injury has not been well elucidated.

This study investigates the utility of near-infrared spectroscopy (NIRS), a non-invasive oxygen-measuring device, to identify preterm infants at highest risk for brain injury or death.

Conditions

  • Intraventricular Hemorrhage of Prematurity
  • Complications of Prematurity

Interventions

DEVICE

NIRS monitoring

All enrolled infants will undergo NIRS monitoring of cerebral oxygenation in addition to monitoring of continuous arterial blood pressure.

Sponsors & Collaborators

Principal Investigators

  • Valerie Chock, MD · Stanford University

  • Krisa Van Meurs, MD · Stanford University

Eligibility

Max Age
24 Hours
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-05-31
Primary Completion
2017-12-31
Completion
2018-03-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02147769 on ClinicalTrials.gov